Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Study offers hope of early detection, treatment of liver cancer

Liver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cure -- but now a study offers hope of early detection, and targets for new treatments.

31 Oct 2018

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.

31 Oct 2018

World’s first vaccine against coeliac disease to be tested in Australia

US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.

31 Oct 2018

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

AEGEA Medical, Inc. has announced the commencement of the Post-Ablation Cavity Access (PACE II) clinical study in women who previously underwent endometrial ablation as part of AEGEA's pivotal trial of the company's patented Adaptive Vapor Ablation technology.

30 Oct 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reimagining nuclei, the DNA-storage compartments of our cells, as miniature lava lamps.

30 Oct 2018

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Immunotherapy -- harnessing T-cells to attack cancer cells in the body -- has given hope to patients who endure round after round of treatment, including chemotherapy, to little effect. For all of its promise, however, immunotherapy still benefits only a minority of patients -- a reality driving research in the field for ways to improve the relatively new approach.

30 Oct 2018

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.

30 Oct 2018

DIACARTA introduces new QClamp assays for detection of cancer gene mutations

DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe based QClamp assays for detection of common cancer mutations in genes, such as KRAS, NRAS, BRAF, EGFR, PIK3CA and JAK2, using tissue biopsyand liquid biopsy samples.

29 Oct 2018

Samara scholars assessed a new way of skin cancer early diagnostics

A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre tested a new way of skin cancer early diagnostics with the help of original complex of three devices.

25 Oct 2018

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.

23 Oct 2018

New medical navigation system receives international innovation award

The team behind a new medical navigation system which makes it easier to take biopsy samples from the lungs recently received an international innovation award during Innovation Expo 2018 in Rotterdam.

23 Oct 2018

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

An interview with Dr.

From Huron Digital Pathology 23 Oct 2018

Map of human liver cells reveals molecular make-up of individual cells

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

From 10x Genomics, Inc. 23 Oct 2018

AI pathology diagnostic tool developed using deep learning technology from Olympus

Since 2017, Olympus Corporation has participated in a joint research program that has the potential to help streamline the workload of clinical pathologists, called “A New Approach to Develop Computer-Aided Diagnosis Using Artificial Intelligence (AI) for Gastric Biopsy Specimens”.

From Evident Corporation - Life Sciences 18 Oct 2018

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans, according to research led by UCSF Benioff Children’s Hospitals and Children’s National Health System.

16 Oct 2018

Study pinpoints new marker that can predict Crohn’s disease subtype

Crohn's disease, a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years.

16 Oct 2018

Researchers successfully develop in vivo skin imaging technology

A Research and Development group led by Professor Yoshifumi Saijo of Tohoku University and Noriyuki Masuda of Advantest has succeeded in developing in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic images and ultrasound images.

12 Oct 2018

Baseline PSA levels measured at midlife predict risk of aggressive prostate cancer in black men

Black men are more likely to be diagnosed with, and to die from, prostate cancer yet recommendations about prostate cancer screening are primarily based on studies of white men.

11 Oct 2018

Co-Diagnostics awarded patent related to its CoPrimer platform technology

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that it has been awarded a patent from the United States Patent and Trademark Office related to the Company's CoPrimer™ platform technology.

10 Oct 2018

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs, a study to be presented at ESMO 2018 reported.

10 Oct 2018

Biopsy News and Research

Further Reading

Study offers hope of early detection, treatment of liver cancer

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

World’s first vaccine against coeliac disease to be tested in Australia

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

DIACARTA introduces new QClamp assays for detection of cancer gene mutations

Samara scholars assessed a new way of skin cancer early diagnostics

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

New medical navigation system receives international innovation award

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Map of human liver cells reveals molecular make-up of individual cells

AI pathology diagnostic tool developed using deep learning technology from Olympus

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

Study pinpoints new marker that can predict Crohn’s disease subtype

Researchers successfully develop in vivo skin imaging technology

Baseline PSA levels measured at midlife predict risk of aggressive prostate cancer in black men

Co-Diagnostics awarded patent related to its CoPrimer platform technology

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News